Summary
The Hawaiʻi Intermediate Court of Appeals held that the District Court exceeded its authority under Hawaiʻi Revised Statutes § 291E-61 by requiring the defendant to appear for compliance hearings in connection with an operating-under-the-influence conviction. The court reversed the September 9, 2024 Compliance Hearings Order.
Topics
Practice areas
Questions Presented
- Whether the District Court had statutory authority under HRS § 291E-61 to require compliance hearings in an OVUII case while keeping part of the sentence under advisement.
- Whether the District Court erred by using compliance hearings as a form of probation or court supervision to monitor substance-abuse treatment and rehabilitation.
Holdings
- The District Court exceeded its authority under HRS § 291E-61 because no statutory authority supported requiring Pascubillo to appear for compliance hearings while keeping part of his OVUII sentence under advisement.
- The District Court erred in entering the September 9, 2024 Compliance Hearings Order.
Key quotations
“There is no statutory authority supporting the District Court's use of compliance hearings, while keeping part of Pascubillo's OVUII sentence "under advisement" in this manner, regardless of the specific purpose of the compliance hearings.” (3)
Factual background
Pascubillo pleaded no contest to OVUII and was sentenced to complete a substance-abuse assessment and a 14-hour substance-abuse rehabilitation program. The District Court took a $250 Drug Demand Reduction Fee under advisement for one year on the condition that he have no further similar violations and set compliance hearings. The compliance-hearings order described the hearings as reviewing compliance with the treatment components of the OVUII judgment. The fee was later waived in an amended judgment.
Procedural history
Pascubillo pleaded no contest to, among other offenses, operating a vehicle under the influence of an intoxicant under HRS § 291E-61(a)(1). The District Court imposed substance-abuse assessment and rehabilitation requirements, took a $250 Drug Demand Reduction Fee under advisement for one year, and ordered compliance hearings. After Pascubillo moved to strike the hearings, the District Court denied the motion. The District Court later entered an amended judgment waiving the fee, and Pascubillo appealed the compliance-hearings order.